Name:	O
___	O
Unit	O
No:	O
___	O
Admission	O
Date:	O
___	O
Discharge	O
Date:	O
___	O
Date	O
of	O
Birth:	O
___	O
Sex:	O
M	O
Service:	O
MEDICINE	O
Allergies:	O
Patient	O
recorded	O
as	O
having	O
No	O
Known	O
Allergies	O
to	O
Drugs	O
Attending:	O
___	O
Chief	O
Complaint:	O
Shortness	O
of	O
Breath	O
Major	O
Surgical	O
or	O
Invasive	O
Procedure:	O
None	O
History	O
of	O
Present	O
Illness:	O
___	O
yo	O
___	O
speaking	O
M,	O
with	O
hx	O
of	O
CAD	O
s/p	O
MI	O
___	O
years	O
ago,	O
s/p	O
pacemaker	O
placement	O
for	O
bradycardia	O
requiring	O
shock	O
who	O
was	O
admitted	O
for	O
___.	O
.	O
Patient	O
was	O
in	O
his	O
usual	O
state	O
of	O
health	O
and	O
feeling	O
fine	O
this	O
morning.	O
___	O
came	O
to	O
take	O
his	O
VS	O
(recent	O
discharge	O
for	O
PNA)	B-Lower_respiratory_tract_infection
and	O
he	O
was	O
found	O
to	O
be	O
asymptomatically	O
tachycardic	O
to	O
111.	O
He	O
called	O
his	O
PCP	O
who	O
recommended	O
that	O
he	O
come	O
to	O
the	O
ED	O
for	O
evaluation.	O
Of	O
note,	O
patient	O
has	O
had	O
2	O
recent	O
admissions	O
in	O
the	O
last	O
2	O
months,	O
one	O
for	O
PNA	B-Lower_respiratory_tract_infection
and	O
one	O
for	O
new	O
acute	O
CHF.	O
Patient	O
reports	O
that	O
he	O
had	O
no	O
chest	O
pressure	O
or	O
pain	O
-	O
however	O
per	O
ED	O
report	O
he	O
did	O
report	O
that	O
he	O
had	O
chest	O
pressure	O
upon	O
questioning	O
in	O
the	O
ED.	O
.	O
In	O
the	O
ED,	O
triage	O
vitals	O
were:	O
97.9	O
88	O
110/64	O
16	O
100%	O
on	O
room	O
air.	O
Patient	O
had	O
diffuse	O
wheezed.	O
He	O
received	O
Albuterol	O
0.083%	O
Neb,	O
Ipratropium	O
Bromide	O
Neb,	O
Aspirin	O
325mg	O
and	O
PredniSONE	O
60	O
mg	O
Tablet.	O
CXR:	O
No	O
air	O
space	O
consolidation,	O
no	O
acute	O
intrathoracic	O
process.	O
The	O
ED	O
was	O
prepared	O
to	O
discharge	O
him	O
from	O
the	O
ED	O
but	O
the	O
patient's	O
PCP	O
requested	O
admission	O
for	O
___.	O
.	O
Upon	O
transfer	O
to	O
the	O
floor,	O
history	O
was	O
taken	O
with	O
a	O
phone	O
interpreter.	O
Patient	O
reports	O
that	O
he	O
feels	O
at	O
his	O
baseline	O
other	O
than	O
being	O
slightly	O
warm.	O
He	O
denies	O
CP,	O
SOB,	O
palipatations,	O
N/V/D,	O
change	O
in	O
urinary	O
or	O
bowel	O
habits.	O
.	O
ROS:	O
Denies	O
fever,	O
chills,	O
headache,	O
abdominal	O
pain,	O
nausea,	O
vomiting,	O
diarrhea,	O
constipation,	B-Constipation
dysuria,	O
hematuria.	O
.	O
Past	O
Medical	O
History:	O
-PMR	O
in	O
past,	O
treated	O
with	O
steriods	O
-	O
___	O
biventricular	O
Pacemaker	O
placed	O
in	O
___	O
___,indicated	O
for	O
symptomatic	O
bradycarida	O
-CAD,	O
MI	O
___	O
yrs	O
ago	O
-	O
Heart	O
Failure	O
with	O
preserved	O
EF	O
and	O
mildly	O
increased	O
LVEDP	O
-Prostate	O
Ca	O
with	O
radioactive	O
beads	O
placed	O
___	O
-Cataracts	O
-	O
Centrilobular	O
Emphysema	O
with	O
reactive	O
airway	O
component.	O
-pulmonary	O
nodules	O
with	O
hilar	O
LAD	O
not	O
specified	O
if	O
related	O
to	O
occupational	O
exposure	O
(metal	O
dust	O
at	O
work),	O
was	O
told	O
___	O
years	O
ago	O
has	O
metal	O
dust	O
in	O
lung	O
parenchyma	O
(CT	O
f/u	O
___	O
Social	O
History:	O
___	O
Family	O
History:	O
Denies	O
any	O
family	O
history.	O
Physical	O
Exam:	O
Vitals	O
-	O
T:98	O
BP:135/75	O
HR:	O
81	O
RR:	O
18	O
100%	O
on	O
RA	O
GENERAL:	O
NAD,	O
___	O
speaking	O
male,	O
sitting	O
in	O
bed	O
HEENT:	O
clear	O
OP,	O
MMM,	O
clear	O
conjuctiva	O
NECK:	O
supple,	O
no	O
JVD,	O
no	O
LAD	O
CARDIAC:	O
distant	O
heart	O
sounds,	O
regular	O
rate,	O
no	O
murmur	O
LUNG:	O
Mild	O
diffuse	O
expiratory	O
wheezes	O
with	O
prolong	O
expiratory	O
phase	O
in	O
upper	O
lung	O
fields	O
L	O
>	O
R.	O
No	O
dullness	O
to	O
percussion.	O
ABDOMEN:	O
soft,	O
NT,	O
obese,	O
no	O
HSM,	O
+BS	O
EXT:	O
no	O
___,	O
warm,	O
well	O
perfused.	O
NEURO:	O
A&O	B-Delirium
x	B-Delirium
3,	B-Delirium
strength	O
wnl,	O
cn	O
___	O
grossly	O
intact	O
DERM:	O
no	O
rash	O
Pertinent	O
Results:	O
___	O
07:30PM	O
URINE	O
BLOOD-NEG	O
NITRITE-NEG	O
PROTEIN-NEG	O
GLUCOSE-NEG	O
KETONE-NEG	O
BILIRUBIN-NEG	O
UROBILNGN-NEG	O
PH-5.0	O
LEUK-NEG	O
___	O
07:05PM	O
cTropnT-<0.01	O
___	O
02:30AM	O
cTropnT-<0.01	O
___	O
1:00PM	O
cTropnT-<0.01	O
___	O
07:05PM	O
CK-MB-6	O
___	O
07:05PM	O
WBC-9.9	O
RBC-4.47*	O
HGB-12.9*	O
HCT-38.1*	O
MCV-85	O
MCH-28.7	O
MCHC-33.8	O
RDW-14.2	O
___	O
07:05PM	O
GLUCOSE-109*	O
UREA	O
N-15	O
CREAT-1.1	O
SODIUM-137	O
POTASSIUM-4.5	O
CHLORIDE-102	O
TOTAL	O
CO2-27	O
ANION	O
GAP-___	O
yo	O
___	O
speaking	O
M,	O
with	O
hx	O
of	O
CAD	O
s/p	O
MI	O
___	O
years	O
ago,	O
s/p	O
pacemaker	O
placement	O
for	O
bradycardia	O
who	O
was	O
admitted	O
for	O
___	O
after	O
being	O
found	O
tachycardic	O
at	O
117bpm	O
by	O
his	O
___	O
the	O
ED,	O
triage	O
vitals	O
were:	O
97.9	O
88	O
110/64	O
16	O
100%	O
on	O
room	O
air.	O
Patient	O
had	O
diffuse	O
wheezes.	O
He	O
received	O
Albuterol	O
0.083%	O
Neb,	O
Ipratropium	O
Bromide	O
Neb,	O
Aspirin	O
325mg	O
and	O
PredniSONE	O
60	O
mg	O
Tablet,	O
which	O
resolved	O
his	O
dyspnea,	O
CXR	O
in	O
ED	O
showed	O
No	O
air	O
space	O
consolidation,	O
no	O
acute	O
intrathoracic	O
process.	O
Ekg	O
revealed	O
a	O
ventricular	O
paced	O
rhythm	O
with	O
a	O
rate	O
of	O
89bpm	O
with	O
no	O
ST	O
or	O
T	O
wave	O
ischemic	O
changes.	O
Upon	O
transfer	O
to	O
the	O
floor,	O
history	O
was	O
taken	O
with	O
a	O
phone	O
interpreter.	O
Patient	O
reports	O
that	O
he	O
felt	O
at	O
his	O
baseline	O
other	O
than	O
being	O
slightly	O
warm.	O
He	O
denied	O
CP,	O
SOB,	O
palipatations,	O
N/V/D,	O
change	O
in	O
urinary	O
or	O
bowel	O
habits.	O
He	O
had	O
an	O
uneventful	O
night	O
and	O
had	O
no	O
more	O
episodes	O
of	O
chest	O
pain	O
and	O
his	O
sob	O
was	O
greatly	O
improved	O
with	O
prn	O
albuterol	O
and	O
atrovent	O
q6	O
hours.	O
He	O
was	O
also	O
ruled	O
out	O
for	O
MI	O
with	O
cardiac	O
enzymes	O
negative	O
x	O
3.	O
He	O
was	O
continued	O
on	O
albuterol	O
prn,	O
and	O
atrovent	O
throughtout	O
his	O
hospital	O
stay.	O
On	O
the	O
day	O
of	O
discharge	O
EP	O
interrogated	O
his	O
PPM	O
and	O
determined	O
it	O
was	O
working	O
normally	O
and	O
needed	O
no	O
further	O
work	O
up	O
for	O
underlying	O
arrythmia.	O
We	O
discharged	O
the	O
patient	O
in	O
stable	O
condition	O
on	O
the	O
same	O
medications	O
he	O
was	O
admitted	O
on.	O
Medications	O
on	O
Admission:	O
1.	O
Atorvastatin	O
40	O
mg	O
Tablet	O
Sig:	O
One	O
(1)	O
Tablet	O
PO	O
DAILY	O
(Daily).	O
2.	O
Metoprolol	O
Succinate	O
100	O
mg	O
Tablet	O
Sustained	O
Release	O
24	O
hr	O
Sig:	O
One	O
(1)	O
Tablet	O
Sustained	O
Release	O
24	O
hr	O
PO	O
DAILY	O
(Daily).	O
3.	O
Aspirin	O
325	O
mg	O
Tablet	O
Sig:	O
One	O
(1)	O
Tablet	O
PO	O
DAILY	O
(Daily).	O
4.	O
Zolpidem	O
5	O
mg	O
Tablet	O
Sig:	O
One	O
(1)	O
Tablet	O
PO	O
ONCE	O
(Once)	O
for	O
1	O
doses.	O
5.	O
Albuterol	O
Sulfate	O
90	O
mcg/Actuation	O
HFA	O
Aerosol	O
Inhaler	O
Sig:	O
___	O
mcg/Actuation	O
HFA	O
Aerosol	O
Inhaler	O
Inhalation	O
four	O
times	O
a	O
day.	O
6.	O
Tiotropium	O
Bromide	O
18	O
mcg	O
Capsule,	O
w/Inhalation	O
Device	O
Sig:	O
One	O
(1)	O
18	O
mcg	O
Capsule	O
Inhalation	O
once	O
a	O
day.	O
7.	O
Omeprazole	O
20	O
mg	O
Capsule,	O
Delayed	O
Release(E.C.)	O
Sig:	O
Two	O
(2)	O
Capsule,	O
Delayed	O
Release(E.C.)	O
PO	O
once	O
a	O
day.	O
8.	O
Furosemide	O
20	O
mg	O
Tablet	O
Sig:	O
One	O
(1)	O
Tablet	O
PO	O
once	O
a	O
day	O
Discharge	O
Medications:	O
1.	O
Atorvastatin	O
40	O
mg	O
Tablet	O
Sig:	O
One	O
(1)	O
Tablet	O
PO	O
DAILY	O
(Daily).	O
2.	O
Metoprolol	O
Succinate	O
100	O
mg	O
Tablet	O
Sustained	O
Release	O
24	O
hr	O
Sig:	O
One	O
(1)	O
Tablet	O
Sustained	O
Release	O
24	O
hr	O
PO	O
DAILY	O
(Daily).	O
3.	O
Aspirin	O
325	O
mg	O
Tablet	O
Sig:	O
One	O
(1)	O
Tablet	O
PO	O
DAILY	O
(Daily).	O
4.	O
Zolpidem	O
5	O
mg	O
Tablet	O
Sig:	O
One	O
(1)	O
Tablet	O
PO	O
ONCE	O
(Once)	O
for	O
1	O
doses.	O
5.	O
Albuterol	O
Sulfate	O
90	O
mcg/Actuation	O
HFA	O
Aerosol	O
Inhaler	O
Sig:	O
___	O
mcg/Actuation	O
HFA	O
Aerosol	O
Inhaler	O
Inhalation	O
four	O
times	O
a	O
day.	O
6.	O
Tiotropium	O
Bromide	O
18	O
mcg	O
Capsule,	O
w/Inhalation	O
Device	O
Sig:	O
One	O
(1)	O
18	O
mcg	O
Capsule	O
Inhalation	O
once	O
a	O
day.	O
7.	O
Omeprazole	O
20	O
mg	O
Capsule,	O
Delayed	O
Release(E.C.)	O
Sig:	O
Two	O
(2)	O
Capsule,	O
Delayed	O
Release(E.C.)	O
PO	O
once	O
a	O
day.	O
8.	O
Furosemide	O
20	O
mg	O
Tablet	O
Sig:	O
One	O
(1)	O
Tablet	O
PO	O
once	O
a	O
day.	O
Discharge	O
Disposition:	O
Home	O
With	O
Service	B-Has_carers
Facility:	O
___	O
Discharge	O
Diagnosis:	O
Primary:	O
1:	O
Shortness	O
of	O
Breath	O
2:	O
Tachycardia	O
Secondary:	O
2:	O
Emphysema	O
with	O
reactive	O
airway	O
component	O
3:	O
Diastolic	O
Heart	O
Failure	O
4:	O
Polymyalgia	O
Rheumatica	O
5:	O
Coronary	O
Artery	O
disease	O
6:	O
Prostate	O
Cancer	O
7:	O
Cataracts	O
8:	O
Complete	O
Heart	O
Block	O
with	O
Pacemaker	O
Discharge	O
Condition:	O
In	O
stable	O
condition	O
without	O
chest	O
pain	O
or	O
shortness	O
of	O
breath.	O
Discharge	O
Instructions:	O
Thank	O
you	O
for	O
allowing	O
us	O
to	O
take	O
care	O
of	O
you	O
here	O
at	O
___	O
___.	O
You	O
were	O
admitted	O
to	O
because	O
your	O
home	O
visiting	O
nurse	O
noticed	O
you	O
heart	O
rate	O
was	O
elevated	O
and	O
you	O
had	O
a	O
mild	O
COPD	B-Lower_respiratory_tract_infection
excacerbatoin.	B-Lower_respiratory_tract_infection
We	O
evaluated	O
your	O
blood	O
to	O
make	O
sure	O
you	O
did	O
not	O
have	O
a	O
heart	O
attack	O
and	O
the	O
results	O
of	O
those	O
studies	O
showed	O
that	O
you	O
did	O
not	O
have	O
any	O
heart	O
damage	O
or	O
heart	O
attack.	O
We	O
also	O
asked	O
cardiologist	O
to	O
examine	O
your	O
pacemaker	O
to	O
identify	O
a	O
possible	O
accelerated	O
rhythm	O
or	O
pacemaker	O
malfunction	O
that	O
could	O
have	O
caused	O
your	O
fast	O
heart	O
rate.	O
They	O
determined	O
that	O
your	O
pacemaker	O
was	O
functioning	O
normally.	O
You	O
were	O
also	O
short	O
of	O
breath	O
during	O
the	O
hospitilzation	O
and	O
were	O
given	O
inhaled	O
nebulizer	O
treatments	O
and	O
one	O
dose	O
of	O
oral	O
steroids	O
to	O
reduce	O
inflammation	O
in	O
your	O
lungs	O
and	O
help	O
you	O
breath	O
better.	O
Please	O
go	O
to	O
an	O
Emergency	O
room	O
if	O
you	O
feel	O
any	O
chest	O
pain,	O
palpitations,	O
severe	O
shortness	O
of	O
breath,	O
swelling	O
of	O
your	O
legs	O
or	O
dizziness.	O
Because	O
of	O
a	O
history	O
of	O
fluid	O
overload	O
please	O
weigh	O
yourself	O
every	O
morning,	O
call	O
MD	O
if	O
weight	O
>	O
3	O
lbs.	O
Adhere	O
to	O
2	O
gm	O
sodium	O
diet	O
Fluid	O
Restriction:	O
less	O
than	O
2L	O
daily	O
.	O
Followup	O
Instructions:	O
___	O

